Benjamin J. Hindson 10x Genomics, Inc. (TXG) insider trading activity

Benjamin J. Hindson is of 10x Genomics, Inc.. Currently has a direct ownership of 339,897 shares of TXG, which is worth approximately $4.96 Million. The most recent transaction as insider was on Nov 22, 2024, when has been sold 5,807 shares (Class A Common Stock) at a price of $13.69 per share, resulting in proceeds of $79,497. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 340K

1.68% 3M change

18.98% 12M change

Total Value Held $4.96 Million

Benjamin J. Hindson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 22 2024	SELL Open market or private sale	$79,497 $13.69 p/Share	5,807 Reduced 1.68%	339,897 Class A Common Stock
Aug 22 2024	SELL Open market or private sale	$98,028 $22.53 p/Share	4,351 Reduced 1.24%	345,704 Class A Common Stock
May 22 2024	SELL Open market or private sale	$99,314 $24.3 p/Share	4,087 Reduced 1.15%	350,055 Class A Common Stock
Mar 21 2024	BUY Grant, award, or other acquisition	-	71,083 Added 16.72%	354,142 Class A Common Stock
Feb 22 2024	SELL Open market or private sale	$121,086 $46.34 p/Share	2,613 Reduced 0.91%	283,059 Class A Common Stock
Dec 28 2023	BUY Exercise of conversion of derivative security	$95,674 $11.48 p/Share	8,334 Added 2.83%	285,672 Class A Common Stock
Nov 22 2023	SELL Open market or private sale	$149,479 $43.34 p/Share	3,449 Reduced 1.23%	277,338 Class A Common Stock
Aug 22 2023	SELL Open market or private sale	$157,895 $45.78 p/Share	3,449 Reduced 1.21%	280,787 Class A Common Stock
Aug 01 2023	SELL Open market or private sale	$432,627 $62.07 p/Share	6,970 Reduced 2.39%	284,236 Class A Common Stock
Aug 01 2023	BUY Exercise of conversion of derivative security	$80,015 $11.48 p/Share	6,970 Added 2.34%	291,206 Class A Common Stock
Jul 19 2023	SELL Open market or private sale	$836,818 $60.03 p/Share	13,940 Reduced 4.68%	284,236 Class A Common Stock
Jul 19 2023	BUY Exercise of conversion of derivative security	$115,144 $8.26 p/Share	13,940 Added 4.47%	298,176 Class A Common Stock
May 23 2023	SELL Open market or private sale	$131,483 $55.06 p/Share	2,388 Reduced 0.83%	284,236 Class A Common Stock
Mar 21 2023	BUY Grant, award, or other acquisition	-	36,387 Added 11.26%	286,624 Class A Common Stock
Feb 22 2023	SELL Open market or private sale	$83,180 $47.75 p/Share	1,742 Reduced 0.69%	250,237 Class A Common Stock
Dec 14 2022	BUY Exercise of conversion of derivative security	$172,700 $5.04 p/Share	34,266 Added 11.97%	251,979 Class A Common Stock
Nov 22 2022	SELL Open market or private sale	$80,439 $34.07 p/Share	2,361 Reduced 1.07%	217,713 Class A Common Stock
Sep 14 2022	BUY Grant, award, or other acquisition	-	33,828 Added 13.32%	220,074 Class A Common Stock
Aug 23 2022	SELL Open market or private sale	$45,465 $35.19 p/Share	1,292 Reduced 0.69%	186,246 Class A Common Stock
May 23 2022	SELL Open market or private sale	$61,633 $48.76 p/Share	1,264 Reduced 0.67%	187,538 Class A Common Stock
Mar 22 2022	BUY Grant, award, or other acquisition	-	28,476 Added 13.11%	188,802 Class A Common Stock
Feb 22 2022	SELL Open market or private sale	$28,292 $78.59 p/Share	360 Reduced 0.22%	160,326 Class A Common Stock
Jan 03 2022	SELL Open market or private sale	$6,119,902 $146.88 p/Share	41,666 Reduced 20.59%	160,686 Class A Common Stock
Jan 03 2022	BUY Exercise of conversion of derivative security	$1,792,888 $43.03 p/Share	41,666 Added 17.07%	202,352 Class A Common Stock
Dec 28 2021	BUY Exercise of conversion of derivative security	$129,869 $1.14 p/Share	113,920 Added 41.48%	160,686 Class A Common Stock

BJH

Benjamin J. Hindson

Pleasanton, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXG shares.

Notify only if

Value

Insider Trading

Get notified when an 10x Genomics, Inc. insider buys or sells TXG shares.

Notify only if

Operation

Value

Type

News

Receive news related to 10x Genomics, Inc.

Track Activities on TXG

Account